Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
7.11
-0.10 (-1.39%)
At close: Apr 28, 2026, 4:00 PM EDT
7.32
+0.21 (2.95%)
After-hours: Apr 28, 2026, 7:08 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $439.33 million as of April 28, 2026. Its market cap has increased by 316.94% in one year.
Market Cap
439.33M
Enterprise Value
386.93M
1-Year Change
316.94%
Ranking
Category
Stock Price
$7.11
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $439.33M, an increase of 612.98%. That is a compound annual growth rate of 46.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 445.74M | 16.93% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 465.47M |
| Larimar Therapeutics | 461.24M |
| Candel Therapeutics | 460.72M |
| Ginkgo Bioworks Holdings | 455.18M |
| Prelude Therapeutics | 454.50M |
| Climb Bio | 453.80M |
| Aura Biosciences | 446.83M |
| REGENXBIO | 444.94M |